drugset / Trial / NCT03298906
A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the effects of ticlopidine on the pharmacokinetics (PK) of intranasally administered esketamine.
Timeline
- Start
- 2017-09-26
- Primary completion
- 2017-11-27
- Completion
- 2017-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 56 mg | Intranasal |
| Subject | ticlopidine | Small molecule | 250 mg | Oral |
Indications
No indication recorded.